Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth.

Ghislin S, Deshayes F, Lauriol J, Middendorp S, Martins I, Al-Daccak R, Alcaide-Loridan C.

Melanoma Res. 2012 Jun;22(3):184-94. doi: 10.1097/CMR.0b013e328351e7c4.

PMID:
22454190
2.

Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.

Ramgolam K, Lauriol J, Lalou C, Lauden L, Michel L, de la Grange P, Khatib AM, Aoudjit F, Charron D, Alcaide-Loridan C, Al-Daccak R.

PLoS One. 2011 Apr 15;6(4):e18784. doi: 10.1371/journal.pone.0018784.

3.

Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment.

Sztiller-Sikorska M, Koprowska K, Jakubowska J, Zalesna I, Stasiak M, Duechler M, Czyz ME.

Melanoma Res. 2012 Jun;22(3):215-24. doi: 10.1097/CMR.0b013e3283531317.

PMID:
22495670
4.

Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.

Borrull A, Ghislin S, Deshayes F, Lauriol J, Alcaide-Loridan C, Middendorp S.

J Cancer Res Clin Oncol. 2012 Jul;138(7):1145-54. doi: 10.1007/s00432-012-1186-2. Epub 2012 Mar 11.

PMID:
22406932
5.

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.

J Cell Physiol. 2007 Aug;212(2):330-44. Review.

PMID:
17458893
6.

Comparative epigenetic analysis of Oct4 regulatory region in RA-induced differentiated NT2 cells under adherent and non-adherent culture conditions.

Favaedi R, Shahhoseini M, Akhoond MR.

Mol Cell Biochem. 2012 Apr;363(1-2):129-34. doi: 10.1007/s11010-011-1165-y. Epub 2011 Dec 9.

PMID:
22160855
7.

Loss of oncostatin M receptor beta in metastatic melanoma cells.

Lacreusette A, Nguyen JM, Pandolfino MC, Khammari A, Dreno B, Jacques Y, Godard A, Blanchard F.

Oncogene. 2007 Feb 8;26(6):881-92. Epub 2006 Aug 7.

PMID:
16909117
8.

Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.

Liu S, Cheng H, Kwan W, Lubieniecka JM, Nielsen TO.

Mol Cancer Ther. 2008 Jun;7(6):1751-61. doi: 10.1158/1535-7163.MCT-07-0560.

9.

Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.

Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, Lassau N, Bourhis J, Deutsch E.

Mol Cancer Ther. 2005 Nov;4(11):1717-28.

10.

Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells.

Sharma R, Ottenhof T, Rzeczkowska PA, Niles LP.

J Pineal Res. 2008 Oct;45(3):277-84. doi: 10.1111/j.1600-079X.2008.00587.x. Epub 2008 Mar 26.

PMID:
18373554
11.

Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment.

Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, Margaryan NV, Seftor EA, Seftor RE, Hendrix MJ.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3752-7. Epub 2006 Feb 27.

12.

A tumorigenic subpopulation with stem cell properties in melanomas.

Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M.

Cancer Res. 2005 Oct 15;65(20):9328-37.

13.

H3K9 acetylation and radial chromatin positioning.

Strasák L, Bártová E, Harnicarová A, Galiová G, Krejcí J, Kozubek S.

J Cell Physiol. 2009 Jul;220(1):91-101. doi: 10.1002/jcp.21734.

PMID:
19248079
14.

Model cell culture system for defining the molecular and biochemical events mediating terminal differentiation of human melanoma cells.

Staudt MR, Depass AL, Sarkar D, Fisher PB.

J Cell Physiol. 2009 Feb;218(2):304-14. doi: 10.1002/jcp.21602.

PMID:
18844238
15.

PHF19 and Akt control the switch between proliferative and invasive states in melanoma.

Ghislin S, Deshayes F, Middendorp S, Boggetto N, Alcaide-Loridan C.

Cell Cycle. 2012 Apr 15;11(8):1634-45. doi: 10.4161/cc.20095. Epub 2012 Apr 15.

PMID:
22487681
16.

Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo.

Fujita M, Norris DA, Yagi H, Walsh P, Morelli JG, Weston WL, Terada N, Bennion SD, Robinson W, Lemon M, Maxwell IH, Yohn JJ.

Melanoma Res. 1999 Jun;9(3):279-91.

PMID:
10465584
17.

Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.

Peretz Y, Wu H, Patel S, Bellacosa A, Katz RA.

PLoS One. 2015 Feb 2;10(2):e0116839. doi: 10.1371/journal.pone.0116839. eCollection 2015.

18.

MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.

Garrido C, Paco L, Romero I, Berruguilla E, Stefansky J, Collado A, Algarra I, Garrido F, Garcia-Lora AM.

Carcinogenesis. 2012 Mar;33(3):687-93. doi: 10.1093/carcin/bgr318. Epub 2012 Jan 4.

PMID:
22219178
19.

In vivo switching of human melanoma cells between proliferative and invasive states.

Hoek KS, Eichhoff OM, Schlegel NC, Döbbeling U, Kobert N, Schaerer L, Hemmi S, Dummer R.

Cancer Res. 2008 Feb 1;68(3):650-6. doi: 10.1158/0008-5472.CAN-07-2491.

20.

[Phenotypic plasticity of neural crest-derived melanocytes and Schwann cells].

Dupin E.

Biol Aujourdhui. 2011;205(1):53-61. doi: 10.1051/jbio/2011008. Epub 2011 Apr 19. Review. French.

PMID:
21501576

Supplemental Content

Support Center